Research analysts at Zacks Research boosted their Q1 2027 EPS estimates for shares of Guidewire Software in a research note ...
Equities researchers at Zacks Research reduced their Q3 2025 earnings per share (EPS) estimates for shares of Zscaler in a ...
Stocks in Japan tumbled nearly 4 percent as investors braced for a week of market turmoil caused by an expected announcement ...
When consumers and businesses are feeling down, the effects can ripple through the economy—sometimes.
From New York to London and Hong Kong, investors are cutting back risk ahead of next week’s tariff announcements, while ...
Should you flee the stock market? Not at all. Instead, to protect your portfolio, here are three things every investor should do.
2d
Zacks Investment Research on MSNUiPath, Inc. (PATH) Is a Trending Stock: Facts to Know Before Betting on ItUiPath (PATH) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...
2d
Zacks Investment Research on MSNAmgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should KnowAmgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...
AAR Corp. (AIR) on Thursday reported a fiscal third-quarter loss of $8.9 million, after reporting a profit in the same ...
Cytokinetics (CYTK) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate ...
Given the legal uncertainties, macroeconomic risks, and disappointing earnings guidance, it is prudent to sell CRWD stock for ...
Both Nasdaq and the New York Stock Exchange are in the process of making round-the-clock trading available five or even seven ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results